Foghorn Therapeutics (FHTX) EBT Margin Growth (1y) (2021 - 2026)
Foghorn Therapeutics (FHTX) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Foghorn Therapeutics | 352.57 Mn | 263.66 Mn | - | -208,224.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -208,224.00 |
| Dec 31, 2025 | 42,497.00 |
| Sep 30, 2025 | -26,719.00 |
| Jun 30, 2025 | -72,221.00 |
| Mar 31, 2025 | 10,923.00 |
| Dec 31, 2024 | -29,945.00 |
| Sep 30, 2024 | -16,705.00 |
| Jun 30, 2024 | 17,621.00 |
| Mar 31, 2024 | 6,836.00 |
| Dec 31, 2023 | 30,696.00 |
| Sep 30, 2023 | 31,059.00 |
| Jun 30, 2023 | 9,848.00 |
| Mar 31, 2023 | 12,286.00 |
| Dec 31, 2022 | 444,299.00 |
| Sep 30, 2022 | 24.43 Mn |
| Jun 30, 2022 | 3.52 Mn |
| Mar 31, 2022 | 822,985.00 |
| Dec 31, 2021 | 411,244.00 |
| Sep 30, 2021 | -18.81 Mn |